New Biological Insights and Recent Therapeutic Advances in the Management of Lung Cancer: A Clinical Investigator Think Tank


A patient whose tumor was ALK wild type by FISH testing but subsequently identified by NGS as ALK rearranged
1:40 minutes.

ALK-Rearranged, Advanced NSCLC

EGFR Mutation-Positive, Advanced NSCLC

Next-Generation Sequencing; Other Actionable Mutations

Immunotherapy in NSCLC

Pan-Wild-Type, Advanced NSCLC

Adjuvant Therapy for Localized NSCLC